Insider · CIK 0001769127

CATHERS BRIAN EDWIN

Reports to the SEC for 1 company · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001769127

Forms 4 and 5

Insider transactions

26 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-03-01	Global Blood Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+3,750 sh	—	—	13,302
2021-03-01	Global Blood Therapeutics, Inc.F Tax Payment	Chief Scientific Officer	FTax Payment	−1,297 sh	$44.48	−$57.7K	12,005
2021-03-01	Global Blood Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−3,750 sh	—	—	15,000
2021-03-01	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+31.1K sh	—	—	31,082
2021-03-01	Global Blood Therapeutics, Inc.Restricted Stock UnitsA Award	Chief Scientific Officer	AAward	+17.7K sh	—	—	17,733
2021-02-01	Global Blood Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−3,020 sh	—	—	18,120
2021-02-01	Global Blood Therapeutics, Inc.A Award	Chief Scientific Officer	AAward	+267 sh	$41.17	+$11K	7,710
2021-02-01	Global Blood Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+3,020 sh	—	—	10,730
2021-02-01	Global Blood Therapeutics, Inc.F Tax Payment	Chief Scientific Officer	FTax Payment	−1,178 sh	$49.49	−$58.3K	9,552
2020-09-01	Global Blood Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−3,750 sh	—	—	18,750
2020-09-01	Global Blood Therapeutics, Inc.F Tax Payment	Chief Scientific Officer	FTax Payment	−1,551 sh	$60.45	−$93.8K	7,443
2020-09-01	Global Blood Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+3,750 sh	—	—	8,994
2020-08-20	Global Blood Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−2,200 sh	$63.77	−$140K	5,244
2020-08-01	Global Blood Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+3,020 sh	—	—	8,489
2020-08-01	Global Blood Therapeutics, Inc.F Tax Payment	Chief Scientific Officer	FTax Payment	−1,045 sh	$67.48	−$70.5K	7,444
2020-08-01	Global Blood Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−3,020 sh	—	—	21,140
2020-07-31	Global Blood Therapeutics, Inc.A Award	Chief Scientific Officer	AAward	+290 sh	$41.17	+$11.9K	5,469
2020-06-01	Global Blood Therapeutics, Inc.Restricted Stock UnitsA Award	Chief Scientific Officer	AAward	+42.4K sh	—	—	42,400
2020-03-01	Global Blood Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−7,500 sh	—	—	22,500
2020-03-01	Global Blood Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+7,500 sh	—	—	7,773
2020-03-01	Global Blood Therapeutics, Inc.F Tax Payment	Chief Scientific Officer	FTax Payment	−2,594 sh	$63.96	−$166K	5,179
2020-02-03	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+38.5K sh	—	—	38,500
2020-02-03	Global Blood Therapeutics, Inc.Restricted Stock UnitsA Award	Chief Scientific Officer	AAward	+24.2K sh	—	—	24,160
2020-01-31	Global Blood Therapeutics, Inc.A Award	Chief Scientific Officer	AAward	+273 sh	$41.17	+$11.2K	273
2019-03-01	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+45K sh	—	—	45,000
2019-03-01	Global Blood Therapeutics, Inc.Restricted Stock UnitsA Award	Chief Scientific Officer	AAward	+30K sh	—	—	30,000

Recent filings

Accepted (ET)
Mar 34
CATHERS BRIAN EDWIN0000899243-21-009561
SEC(opens sec.gov)
Feb 34
CATHERS BRIAN EDWIN0000899243-21-004734
SEC(opens sec.gov)
Sep 34
CATHERS BRIAN EDWIN0000899243-20-024183
SEC(opens sec.gov)
Aug 244
CATHERS BRIAN EDWIN0000899243-20-023299
SEC(opens sec.gov)
Aug 44
CATHERS BRIAN EDWIN0000899243-20-021333
SEC(opens sec.gov)
Jun 34
CATHERS BRIAN EDWIN0000899243-20-015153
SEC(opens sec.gov)
Mar 44
CATHERS BRIAN EDWIN0000899243-20-007086
SEC(opens sec.gov)

Companies

Global Blood Therapeutics, Inc.Chief Scientific Officer

Address

C/O GLOBAL BLOOD THERAPEUTICS, INC. 171 OYSTER POINT BLVD., SUITE 300

SOUTH SAN FRANCISCO, CA, 94080